Program and Abstracts from the Canadian Digestive Diseases Week 2016

Table 20

Patient Characteristics and Clinical Data.

Characteristic	Success	Failed	-value
Age	67.0 (17.4–97.7)	74.3 (23.1–88.4)	0.354
Women	64 (60.4%)	14 (46.7%)	0.180
Diabetes	18 (17%)	8 (26.7%)	0.234
Previous MI	24 (22.6%)	7 (23.3%)	0.936
Recurrent UTI	26 (24.5%)	7 (23.3%)	0.893
Immunosuppressed	21 (19.8%)	11 (36.7%)	0.055
Chronic PPI	50 (47.2%)	19 (63.3%)	0.118
Post-FMT Abx	16 (15.1%)	7 (23.3%)	0.288
Chronic Statin	35 (33%)	14 (46.7%)	0.169
IBD	13 (12.3%)	2 (6.7%)	0.388
Charlson Index	4 (0–11)	5 (0–11)	0.013
COPD	13 (12.3%)	10 (33.3%)	0.007
Maximum WBC	13.4 (4.7–45.4)	21.1 (6.7–58.3)	<0.001
Hospital-acquired	36 (34%)	21 (70%)	<0.001
Inpatient Status	19 (17.9%)	21 (70%)	<0.001
Refractory to Abx	0	9 (30%)	<0.001
Severe/complicated	6 (5.7%)	11 (36.7%)	<0.001

Median (range); Use for >12 weeks before FMT; For reasons other than CDI; Maximum count during any recurrence; Complete non-responsiveness to antibiotics.